adampearce

10 POSTS 0 COMMENTS

ACC 2021: VOYAGER-PAD analysis shows totality of ischaemic events reduced following rivaroxaban use

Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about the VOYAGER-PAD trial,...

Two-year Evolut Low Risk trial data shows “very favourable outcomes” for TAVI compared with SAVR

 John Forrest (New Haven, USA) sits down with Cardiovascular News to talk about the full two-yea...

EuroPCR 2021: Elective coronary revascularisation leads to “significant and robust reduction” of cardiac mortality compared with medical therapy alone

 Eliano Navarese (Bydgoszcz, Poland) talks to Cardiovascular News about a large-scale meta-analy...

ACC 2021: Long-term blood pressure control the “holy grail” for renal denervation in patients with resistant hypertension

 Ajay Kirtane (New York, USA) talks to Cardiovascular News about the RADIANCE-HTN TRIO trial whi...

CRT 2021: Biodegradable polymer sirolimus-eluting stent shows ‘promising’ results in STEMI patients

Thomas Pilgrim (Bern, Switerland) details two-year results from the BIOSTEMI randomised trial, whi...

NACMI registry offers insights into STEMI trends among COVID-19 patients

Tim Henry (Cincinnati, USA) talks to Cardiovascular News about the initial findings from the Nor...

Roxana Mehran on managing ischaemic benefit vs. bleeding harm in HBR patients (A three-part series)

Please NOTE: This video is ONLY available to watch in selected countries and geographiesJTVCZ2VvaXAt...

PROGRESS PVL: One-year safety and performance outcomes for the ACURATE neo Aortic Valve System

NOTE: This video is ONLY available to watch in selected countries and geographies Won-K...

TCT Connect 2020: Online interventional education in the COVID-19 age

Ahead of the first virtual edition of the Transcatheter Cardiovascular Therapeutics (TCT) meetin...

Study shows LAAO reduces major bleeding and mortality compared with NOACs in high-risk AF patients

Jens Erik Nielsen-Kudsk (Aarhus, Denmark) speaks to Cardiovascular News about a propensity score...